“Biotherapeutic manufacturers are faced with developing more product of better, first-time quality at less total manufactured cost,” said Ken Ludwig, business manager, bioprocess and cell therapy at Corning Life Sciences. “To meet and exceed the needs of these customers, we seek ways to deliver innovative technologies to the market that improve results, increase efficiencies and lower costs. Our collaboration with TAP is another proof point of that commitment and to our focus on both automation and bioprocess.”  

 

This latest project follows a number of successful collaborations between the two companies. These include implementing Corning cryogenic vials on TAP’s Fill It automated dispensing system, and HYPERFlask cell culture vessels on TAP’s CompacT SelecT automated cell culture system.  

 

“TAP is excited to be working on another custom project with Corning Life Sciences,” said Dave Thomas, product manager, Integrated Cell Culture Systems, TAP Biosystems. “There is a strong need for automated tools to improve production efficiency and we believe that the combination of Corning and TAP expertise will provide a significant step forward in this area.”  

 

The HYPERStack cell culture vessel features a unique, multi-layered design based on Corning’s gas-permeable film technology and delivers more cells in the same volumetric footprint compared to current stacked-plate products. The increased surface area enables researchers to produce more cells from the same cell population and reduce variability, as well as use fewer vessels, which saves space and labor.  

 

Corning’s cell culture vessels for bioprocessing support suspension and attachment culture in various capacities and provide solutions from cell line development, to seed train, to manufacturing.